about
A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing miceMessenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells.Production of Adjuvant-Loaded Biodegradable Particles for Use in Cancer Vaccines.A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells.TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function.TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot study.Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.Combination therapy with the type II anti-CD20 antibody obinutuzumab.
P2860
Q37222176-EF034D2C-7AB4-4AC9-AEF1-01925C87D168Q38849182-80FCAB5A-AE45-4D48-8D80-83453E5E7DB4Q39310298-406B5C10-378F-4E21-AE4B-36887FFF31BAQ41000160-E3E30FC9-569C-43EF-8970-D33A97FFABE6Q41968526-415A9EC7-2779-4731-AFF3-1B120F1B2B6FQ42484943-B64CF9F7-B0B0-49E7-A6C5-1E44BC348D94Q46050934-F413C349-C1A0-47E0-8203-1CDEB59C0D7FQ47898168-4AC6ECD7-04BB-4E95-A916-BA35D3B88024
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Modes of action of TLR7 agonists in cancer therapy.
@en
type
label
Modes of action of TLR7 agonists in cancer therapy.
@en
prefLabel
Modes of action of TLR7 agonists in cancer therapy.
@en
P2093
P2860
P356
P1433
P1476
Modes of action of TLR7 agonists in cancer therapy.
@en
P2093
Gabriela Wiedemann
Sebastian Kobold
Simon Rothenfußer
Stefan Endres
P2860
P304
P356
10.2217/IMT.14.75
P577
2014-01-01T00:00:00Z